Showing results (201-210 of 311) with videos related to
Sort By:
Pageof 32
Clinical & Experimental Ophthalmology|March 20, 2014
Does levodopa improve vision in albinism? Results of a randomized, controlled clinical trialC Gail Summers, John E Connett, Ann M Holleschau, et al.Molecular Microbiology|December 28, 2022
Phosphorylation chemistry of the Bordetella PlrSR TCS and its contribution to bacterial persistence in the lower respiratory tractSarah A Barr, Emily N Kennedy, Liliana S McKay, et al.Archives of Disease in Childhood|March 6, 1998
An unusually severe phenotype for familial adenomatous polyposisD M Eccles, P W Lunt, Y Wallis, et al.Molecular Cancer Therapeutics|August 19, 2007
AZD6244 (ARRY-142886), a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 kinases: mechanism of action in vivo, pharmacokinetic/pharmacodynamic relationship, and potential for combination in preclinical modelsBarry R Davies, Armelle Logie, Jennifer S McKay, et al.Cells|March 11, 2023
Zinc Supplementation Induced Transcriptional Changes in Primary Human Retinal Pigment Epithelium: A Single-Cell RNA Sequencing Study to Understand Age-Related Macular DegenerationEszter Emri, Oisin Cappa, Caoimhe Kelly, et al.Chembiochem : a European Journal of Chemical Biology|May 23, 2014
A new chemical probe for phosphatidylinositol kinase activityAllison R Sherratt, Neda Nasheri, Craig S McKay, et al.Journal of Clinical Laser Medicine & Surgery|September 19, 2003
A preliminary investigation into light-modulated replication of nanobacteria and heart diseaseAndrei P Sommer, Uri Oron, Anne-Marié Pretorius, et al.Developmental Cell|August 20, 2019
Quiescent Cells Actively Replenish CENP-A Nucleosomes to Maintain Centromere Identity and Proliferative PotentialS Zachary Swartz, Liliana S McKay, Kuan-Chung Su, et al.Glia|January 1, 1997
Contrasting effects of mitogenic growth factors on oligodendrocyte precursor cell migrationR Milner, H J Anderson, R F Rippon, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2008
Constraint-Induced Movement therapy can improve hemiparetic progressive multiple sclerosis. Preliminary findingsV W Mark, E Taub, K Bashir, et al.Pageof 32